Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.5%

3 terminated/withdrawn out of 66 trials

Success Rate

90.6%

+4.1% vs industry average

Late-Stage Pipeline

21%

14 trials in Phase 3/4

Results Transparency

0%

0 of 29 completed trials have results

Key Signals

13 recruiting

Enrollment Performance

Analytics

N/A
24(60.0%)
Phase 4
10(25.0%)
Phase 3
4(10.0%)
Phase 2
2(5.0%)
40Total
N/A(24)
Phase 4(10)
Phase 3(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (66)

Showing 20 of 66 trials
NCT05182658Phase 3Active Not Recruiting

Empagliflozin in Hypertrophic Cardiomyopathy

Role: lead

NCT07450287Not Yet Recruiting

CardioNETPOL National Registry of Carcinoid Heart Disease

Role: lead

NCT07330622Recruiting

Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions

Role: lead

NCT05977842Completed

Drug-coated Balloon in de Novo Chronic Total Occlusions

Role: lead

NCT06878729Not ApplicableRecruiting

Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI

Role: lead

NCT06275386Not ApplicableRecruiting

Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention

Role: lead

NCT07144189Recruiting

AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography

Role: lead

NCT07254572Phase 4Recruiting

Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes

Role: lead

NCT07240441Not ApplicableRecruiting

Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT)

Role: collaborator

NCT04705337Phase 4Terminated

Levosimendan In Ambulatory Heart Failure Patients

Role: collaborator

NCT06838611Recruiting

ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation

Role: collaborator

NCT05660798Not ApplicableRecruiting

Effects of Switching From Cigarettes to Tobacco Heating System on Coronary Atherosclerosis Progression

Role: lead

NCT05305612Phase 4Enrolling By Invitation

Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

Role: lead

NCT06714019Enrolling By Invitation

PL_GNT01_ISR_Grant 53234273

Role: lead

NCT04691778Not ApplicableCompleted

Coronary CTO PCI Using Antegrade Wiring Strategy With a First-choice Gladius Guidewire (Gladius First)

Role: lead

NCT06584266Recruiting

Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

Role: collaborator

NCT05660811Phase 4Recruiting

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients

Role: lead

NCT05882136Completed

Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System

Role: lead

NCT06275763Phase 4Unknown

Optimal Medical Treatment of Difficult-to-treat Hypertension

Role: lead

NCT04465526Completed

The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography

Role: lead